Megace es and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Megace es (megestrol acetate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Nexium, and have High blood pressure.

The phase IV clinical study analyzes which people have Sepsis when taking Megace es. It is created by eHealthMe based on reports of 601 people who have side effects when taking Megace es from the FDA, and is updated regularly.

What is Megace es?

Megace es has active ingredients of megestrol acetate. eHealthMe is studying from 611 Megace es users. Check the latest studies of Megace es.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,522 drugs and 3,259 conditions by eHealthMe. Check the latest studies of Sepsis.

On Jul, 08, 2026

601 people reported to have side effects when taking Megace es.
Among them, 15 people (2.5%) have Sepsis.

Among these 15 people:

How long have people been on Megace es when they have Sepsis? *

What is the gender of people who have Sepsis when taking Megace es? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Sepsis when taking Megace es? *

What are other drugs people take besides Megace es? *

What are other side effects people have besides Sepsis? *

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 5 people, 33.33%
Pneumonia: 5 people, 33.33%
Electrolyte Imbalance: 4 people, 26.67%
Thrombocytopenia (decrease of platelets in blood): 4 people, 26.67%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 3 people, 20.00%
Dehydration (dryness resulting from the removal of water): 3 people, 20.00%
Hypotension (abnormally low blood pressure): 3 people, 20.00%
Haemoglobin Decreased: 2 people, 13.33%
Malignant Neoplasm Progression (cancer tumour came back): 2 people, 13.33%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 13.33%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 46.67%
Abdominal Discomfort: 6 people, 40.00%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 6 people, 40.00%
Fungal Infection: 6 people, 40.00%
Stress And Anxiety: 6 people, 40.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 40.00%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 6 people, 40.00%
Lipids Increased (excess lipid in body): 6 people, 40.00%
Bladder Disorder: 6 people, 40.00%
Platelet Aggregation Abnormal: 6 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take Megace es and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Megace es:

Megace es (611 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Megace es:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,522 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on megestrol acetate (the active ingredients of Megace es) and Megace es (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.